Cervus canadensis isolate Bull #8, Minnesota chromosome 19, ASM1932006v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
A pseudomolecule assembly of the Rocky Mountain elk genome
REFSEQ INFORMATION: The reference sequence is identical to\nCM033209.1.\nAssembly name: ASM1932006v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Iowa State University on\n2021/07/26. The original whole-genome shotgun project has the\naccession JACTMD000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Iowa State University\nAssembly Date :: 24-AUG-2020\nAssembly Method :: MaSuRCA v. MAY-2018\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 686.0x\nSequencing Technology :: PacBio RSII; Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus canadensis Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
NIPA like domain containing 1, transcript variant X1
NIPA like domain containing 1, transcript variant X2
cyclic nucleotide gated channel subunit alpha 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
nuclear transcription factor, X-box binding like 1, transcript variant X1
nuclear transcription factor, X-box binding like 1, transcript variant X4
nuclear transcription factor, X-box binding like 1, transcript variant X5
nuclear transcription factor, X-box binding like 1, transcript variant X6
nuclear transcription factor, X-box binding like 1, transcript variant X7
nuclear transcription factor, X-box binding like 1, transcript variant X8
nuclear transcription factor, X-box binding like 1, transcript variant X9
nuclear transcription factor, X-box binding like 1, transcript variant X2
nuclear transcription factor, X-box binding like 1, transcript variant X3
NF-X1-type zinc finger protein NFXL1 isoform X1
NF-X1-type zinc finger protein NFXL1 isoform X2
NF-X1-type zinc finger protein NFXL1 isoform X3
NF-X1-type zinc finger protein NFXL1 isoform X4
NF-X1-type zinc finger protein NFXL1 isoform X5
NF-X1-type zinc finger protein NFXL1 isoform X6
corin, serine peptidase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
corin, serine peptidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
corin, serine peptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
corin, serine peptidase, transcript variant X1
corin, serine peptidase, transcript variant X5
corin, serine peptidase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
atrial natriuretic peptide-converting enzyme isoform X1
atrial natriuretic peptide-converting enzyme isoform X3
atrial natriuretic peptide-converting enzyme isoform X4
atrial natriuretic peptide-converting enzyme isoform X2
atrial natriuretic peptide-converting enzyme isoform X5
atrial natriuretic peptide-converting enzyme isoform X7
corin, serine peptidase, transcript variant X6
atrial natriuretic peptide-converting enzyme isoform X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATPase phospholipid transporting 10D (putative), transcript variant X2
ATPase phospholipid transporting 10D (putative), transcript variant X1
phospholipid-transporting ATPase VD isoform X2
phospholipid-transporting ATPase VD isoform X1
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
gamma-aminobutyric acid type A receptor subunit beta1, transcript variant X1
gamma-aminobutyric acid type A receptor subunit beta1, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-1 isoform X1
gamma-aminobutyric acid receptor subunit beta-1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
gamma-aminobutyric acid type A receptor subunit alpha4
gamma-aminobutyric acid receptor subunit alpha-4
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase subunit 7B2, mitochondrial
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X3
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X1
gamma-aminobutyric acid receptor subunit alpha-2 isoform X3
gamma-aminobutyric acid receptor subunit alpha-2 isoform X1
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-2 isoform X2
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X1
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-1 isoform X1
gamma-aminobutyric acid receptor subunit gamma-1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69% coverage of the annotated genomic feature by RNAseq alignments
glucosamine-6-phosphate deaminase 2, transcript variant X1
glucosamine-6-phosphate deaminase 2, transcript variant X2
GTP binding elongation factor GUF1, transcript variant X1
GTP binding elongation factor GUF1, transcript variant X2
translation factor GUF1, mitochondrial isoform X1
translation factor GUF1, mitochondrial isoform X2
Yip1 domain family member 7, transcript variant X2
Yip1 domain family member 7, transcript variant X3
Yip1 domain family member 7, transcript variant X1
Yip1 domain family member 7, transcript variant X4
potassium channel tetramerization domain containing 8, transcript variant X1
potassium channel tetramerization domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin and cysteine rich domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 1
ATPase phospholipid transporting 8A1, transcript variant X2
ATPase phospholipid transporting 8A1, transcript variant X3
ATPase phospholipid transporting 8A1, transcript variant X1
phospholipid-transporting ATPase IA isoform X2
phospholipid-transporting ATPase IA isoform X3
phospholipid-transporting ATPase IA isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: BEN domain-containing protein 4
solute carrier family 30 member 9, transcript variant X2
solute carrier family 30 member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LIM and calponin homology domains 1, transcript variant X7
LIM and calponin homology domains 1, transcript variant X2
LIM and calponin homology domains 1, transcript variant X8
LIM and calponin homology domains 1, transcript variant X5
LIM and calponin homology domains 1, transcript variant X3
LIM and calponin homology domains 1, transcript variant X4
LIM and calponin homology domains 1, transcript variant X1
LIM and calponin homology domains 1, transcript variant X9
LIM and calponin homology domains 1, transcript variant X6
LIM and calponin homology domains 1, transcript variant X13
LIM and calponin homology domains 1, transcript variant X15
LIM and calponin homology domains 1, transcript variant X14
LIM and calponin homology domains 1, transcript variant X16
LIM and calponin homology domains 1, transcript variant X12
LIM and calponin homology domains 1, transcript variant X11
LIM and calponin homology domains 1, transcript variant X10
LIM and calponin homology domains 1, transcript variant X18
LIM and calponin homology domains 1, transcript variant X17
LIM and calponin homology domains 1, transcript variant X19
LIM and calponin homology domains-containing protein 1 isoform X15
LIM and calponin homology domains-containing protein 1 isoform X14
LIM and calponin homology domains-containing protein 1 isoform X13
LIM and calponin homology domains-containing protein 1 isoform X12
LIM and calponin homology domains-containing protein 1 isoform X7
LIM and calponin homology domains-containing protein 1 isoform X9
LIM and calponin homology domains-containing protein 1 isoform X2
LIM and calponin homology domains-containing protein 1 isoform X8
LIM and calponin homology domains-containing protein 1 isoform X5
LIM and calponin homology domains-containing protein 1 isoform X3
LIM and calponin homology domains-containing protein 1 isoform X6
LIM and calponin homology domains-containing protein 1 isoform X4
LIM and calponin homology domains-containing protein 1 isoform X1
LIM and calponin homology domains-containing protein 1 isoform X11
LIM and calponin homology domains-containing protein 1 isoform X18
LIM and calponin homology domains-containing protein 1 isoform X17
LIM and calponin homology domains-containing protein 1 isoform X16
LIM and calponin homology domains-containing protein 1 isoform X10
ubiquitin carboxyl-terminal hydrolase isozyme L1
amyloid beta precursor protein binding family B member 2, transcript variant X8
amyloid beta precursor protein binding family B member 2, transcript variant X13
amyloid beta precursor protein binding family B member 2, transcript variant X9
amyloid beta precursor protein binding family B member 2, transcript variant X17
amyloid beta precursor protein binding family B member 2, transcript variant X2
amyloid beta precursor protein binding family B member 2, transcript variant X1
amyloid beta precursor protein binding family B member 2, transcript variant X10
amyloid beta precursor protein binding family B member 2, transcript variant X12
amyloid beta precursor protein binding family B member 2, transcript variant X15
amyloid beta precursor protein binding family B member 2, transcript variant X11
amyloid beta precursor protein binding family B member 2, transcript variant X14
amyloid beta precursor protein binding family B member 2, transcript variant X16
amyloid beta precursor protein binding family B member 2, transcript variant X4
amyloid beta precursor protein binding family B member 2, transcript variant X5
amyloid beta precursor protein binding family B member 2, transcript variant X3
amyloid beta precursor protein binding family B member 2, transcript variant X7
amyloid beta precursor protein binding family B member 2, transcript variant X6
amyloid-beta A4 precursor protein-binding family B member 2 isoform X1
amyloid-beta A4 precursor protein-binding family B member 2 isoform X2
amyloid-beta A4 precursor protein-binding family B member 2 isoform X4
amyloid-beta A4 precursor protein-binding family B member 2 isoform X6
amyloid-beta A4 precursor protein-binding family B member 2 isoform X7
amyloid-beta A4 precursor protein-binding family B member 2 isoform X9
amyloid-beta A4 precursor protein-binding family B member 2 isoform X3
amyloid-beta A4 precursor protein-binding family B member 2 isoform X5
amyloid-beta A4 precursor protein-binding family B member 2 isoform X8
amyloid-beta A4 precursor protein-binding family B member 2 isoform X10
amyloid-beta A4 precursor protein-binding family B member 2 isoform X11
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
amyloid beta precursor protein binding family B member 2, transcript variant X18
amyloid-beta A4 precursor protein-binding family B member 2 isoform X12
NOP2/Sun RNA methyltransferase family member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 ESTs, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
RNA binding motif protein 47, transcript variant X1
RNA binding motif protein 47, transcript variant X12
RNA binding motif protein 47, transcript variant X10
RNA binding motif protein 47, transcript variant X2
RNA binding motif protein 47, transcript variant X4
RNA binding motif protein 47, transcript variant X11
RNA binding motif protein 47, transcript variant X3
RNA binding motif protein 47, transcript variant X6
RNA binding motif protein 47, transcript variant X5
RNA binding motif protein 47, transcript variant X9
RNA binding motif protein 47, transcript variant X8
RNA binding motif protein 47, transcript variant X7
cholinergic receptor nicotinic alpha 9 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor nicotinic alpha 9 subunit, transcript variant X3
neuronal acetylcholine receptor subunit alpha-9 isoform X1
neuronal acetylcholine receptor subunit alpha-9 isoform X3
cholinergic receptor nicotinic alpha 9 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-9 isoform X2
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ras homolog family member H, transcript variant X2
ras homolog family member H, transcript variant X1
ras homolog family member H, transcript variant X3
NEDD4 binding protein 2, transcript variant X3
NEDD4 binding protein 2, transcript variant X5
NEDD4 binding protein 2, transcript variant X1
NEDD4 binding protein 2, transcript variant X4
NEDD4 binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PDS5 cohesin associated factor A, transcript variant X2
PDS5 cohesin associated factor A, transcript variant X1
PDS5 cohesin associated factor A, transcript variant X3
sister chromatid cohesion protein PDS5 homolog A
ubiquitin conjugating enzyme E2 K, transcript variant X2
ubiquitin conjugating enzyme E2 K, transcript variant X3
ubiquitin conjugating enzyme E2 K, transcript variant X4
ubiquitin conjugating enzyme E2 K, transcript variant X1
ubiquitin-conjugating enzyme E2 K isoform X3
ubiquitin-conjugating enzyme E2 K isoform X2
ubiquitin-conjugating enzyme E2 K isoform X1
ubiquitin-conjugating enzyme E2 K isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 1-like
small integral membrane protein 14, transcript variant X1
small integral membrane protein 14, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
small integral membrane protein 14, transcript variant X3
UDP-glucose 6-dehydrogenase, transcript variant X1
UDP-glucose 6-dehydrogenase, transcript variant X2
lipoic acid synthetase, transcript variant X1
lipoic acid synthetase, transcript variant X2
lipoyl synthase, mitochondrial isoform X2
lipoyl synthase, mitochondrial isoform X1
WD repeat domain 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat domain 19, transcript variant X1
WD repeat domain 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat-containing protein 19 isoform X1
WD repeat-containing protein 19 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 5, transcript variant X5
kelch like family member 5, transcript variant X3
kelch like family member 5, transcript variant X4
kelch like family member 5, transcript variant X2
kelch like family member 5, transcript variant X1
transmembrane protein 156, transcript variant X1
transmembrane protein 156, transcript variant X2
transmembrane protein 156, transcript variant X3
family with sequence similarity 114 member A1, transcript variant X2
family with sequence similarity 114 member A1, transcript variant X1
family with sequence similarity 114 member A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
toll like receptor 6, transcript variant X3
toll like receptor 6, transcript variant X2
toll like receptor 6, transcript variant X1
toll like receptor 6, transcript variant X4
toll like receptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 14 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
toll like receptor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 13 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
toll like receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 14 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
toll like receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 14 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
toll like receptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 14 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
toll like receptor 10, transcript variant X1
toll like receptor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122422364, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122422364, transcript variant X1
uncharacterized LOC122422364, transcript variant X2
Kruppel like factor 3, transcript variant X1
Kruppel like factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 365 ESTs, 31 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
jupiter microtubule associated homolog 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 130 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122422339, transcript variant X3
uncharacterized LOC122422339, transcript variant X4
uncharacterized LOC122422339, transcript variant X1
uncharacterized LOC122422339, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1262 ESTs, 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
TBC1 domain family member 1, transcript variant X3
TBC1 domain family member 1, transcript variant X2
TBC1 domain family member 1, transcript variant X1
TBC1 domain family member 1, transcript variant X6
TBC1 domain family member 1, transcript variant X4
TBC1 domain family member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
chromosome 19 C4orf19 homolog, transcript variant X5
chromosome 19 C4orf19 homolog, transcript variant X3
chromosome 19 C4orf19 homolog, transcript variant X1
chromosome 19 C4orf19 homolog, transcript variant X4
chromosome 19 C4orf19 homolog, transcript variant X2
chromosome 19 C4orf19 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55% coverage of the annotated genomic feature by RNAseq alignments
NACHT and WD repeat domain containing 2, transcript variant X1
NACHT and WD repeat domain containing 2, transcript variant X2
NACHT and WD repeat domain containing 2, transcript variant X3
NACHT and WD repeat domain-containing protein 2 isoform X1
NACHT and WD repeat domain-containing protein 2 isoform X2
NACHT and WD repeat domain-containing protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 21 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
translation machinery-associated protein 7-like
stromal interaction molecule 2, transcript variant X2
stromal interaction molecule 2, transcript variant X1
stromal interaction molecule 2 isoform X2
stromal interaction molecule 2 isoform X1
TBC1 domain family member 19, transcript variant X2
TBC1 domain family member 19, transcript variant X1
TBC1 domain family member 19, transcript variant X4
TBC1 domain family member 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 13 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X2
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X1
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X3
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X4
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X6
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X5
recombining binding protein suppressor of hairless isoform X2
recombining binding protein suppressor of hairless isoform X1
recombining binding protein suppressor of hairless isoform X3
recombining binding protein suppressor of hairless isoform X4
recombining binding protein suppressor of hairless isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
small integral membrane protein 20, transcript variant X1
small integral membrane protein 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
small integral membrane protein 20 isoform X1
small integral membrane protein 20 isoform X2
SEL1L family member 3, transcript variant X1
SEL1L family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent phosphate transport protein 2B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 15 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent phosphate transport protein 2B, transcript variant X1
sodium-dependent phosphate transport protein 2B, transcript variant X2
sodium-dependent phosphate transport protein 2B isoform X1
sodium-dependent phosphate transport protein 2B isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
zinc finger CCHC-type containing 4, transcript variant X4
zinc finger CCHC-type containing 4, transcript variant X2
zinc finger CCHC-type containing 4, transcript variant X3
zinc finger CCHC-type containing 4, transcript variant X1
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X4
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X3
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X1
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4-kinase type 2 beta, transcript variant X2
phosphatidylinositol 4-kinase type 2 beta, transcript variant X1
phosphatidylinositol 4-kinase type 2 beta, transcript variant X3
phosphatidylinositol 4-kinase type 2-beta isoform X2
phosphatidylinositol 4-kinase type 2-beta isoform X1
phosphatidylinositol 4-kinase type 2-beta isoform X3
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X3
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X1
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X2
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X3
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X4
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 8 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coiled-coil domain containing 149, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain containing 149, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
coiled-coil domain containing 149, transcript variant X1
coiled-coil domain containing 149, transcript variant X4
coiled-coil domain-containing protein 149 isoform X2
coiled-coil domain-containing protein 149 isoform X3
coiled-coil domain-containing protein 149 isoform X1
coiled-coil domain-containing protein 149 isoform X4
extracellular superoxide dismutase [Cu-Zn]
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
PPARG coactivator 1 alpha, transcript variant X1
PPARG coactivator 1 alpha, transcript variant X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1
PPARG coactivator 1 alpha, transcript variant X4
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X4
PPARG coactivator 1 alpha, transcript variant X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X2
PPARG coactivator 1 alpha, transcript variant X5
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X5
adhesion G protein-coupled receptor A3, transcript variant X1
adhesion G protein-coupled receptor A3, transcript variant X2
adhesion G protein-coupled receptor A3 isoform X1
adhesion G protein-coupled receptor A3 isoform X2
adhesion G protein-coupled receptor A3, transcript variant X3
adhesion G protein-coupled receptor A3 isoform X3
potassium voltage-gated channel interacting protein 4, transcript variant X1
potassium voltage-gated channel interacting protein 4, transcript variant X5
Kv channel-interacting protein 4 isoform X1
Kv channel-interacting protein 4 isoform X5
potassium voltage-gated channel interacting protein 4, transcript variant X4
Kv channel-interacting protein 4 isoform X4
potassium voltage-gated channel interacting protein 4, transcript variant X3
Kv channel-interacting protein 4 isoform X3
potassium voltage-gated channel interacting protein 4, transcript variant X2
Kv channel-interacting protein 4 isoform X2
parkin coregulated like, transcript variant X5
parkin coregulated like, transcript variant X2
parkin coregulated like, transcript variant X1
parkin coregulated like, transcript variant X4
parkin coregulated like, transcript variant X3
slit guidance ligand 2, transcript variant X2
slit guidance ligand 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 11 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
ligand dependent nuclear receptor corepressor like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ligand dependent nuclear receptor corepressor like, transcript variant X3
ligand dependent nuclear receptor corepressor like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
ligand dependent nuclear receptor corepressor like, transcript variant X13
ligand-dependent nuclear receptor corepressor-like protein isoform X9
ligand-dependent nuclear receptor corepressor-like protein isoform X7
ligand-dependent nuclear receptor corepressor-like protein isoform X3
ligand-dependent nuclear receptor corepressor-like protein isoform X10
ligand dependent nuclear receptor corepressor like, transcript variant X8
ligand dependent nuclear receptor corepressor like, transcript variant X9
ligand dependent nuclear receptor corepressor like, transcript variant X7
ligand dependent nuclear receptor corepressor like, transcript variant X5
ligand dependent nuclear receptor corepressor like, transcript variant X4
ligand dependent nuclear receptor corepressor like, transcript variant X2
ligand-dependent nuclear receptor corepressor-like protein isoform X4
ligand-dependent nuclear receptor corepressor-like protein isoform X2
ligand dependent nuclear receptor corepressor like, transcript variant X10
ligand dependent nuclear receptor corepressor like, transcript variant X6
ligand-dependent nuclear receptor corepressor-like protein isoform X6
ligand-dependent nuclear receptor corepressor-like protein isoform X5
ligand dependent nuclear receptor corepressor like, transcript variant X12
ligand-dependent nuclear receptor corepressor-like protein isoform X8
ligand dependent nuclear receptor corepressor like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ligand-dependent nuclear receptor corepressor-like protein isoform X1
DDB1 and CUL4 associated factor 16, transcript variant X2
DDB1 and CUL4 associated factor 16, transcript variant X1
DDB1 and CUL4 associated factor 16, transcript variant X4
DDB1 and CUL4 associated factor 16, transcript variant X3
family with sequence similarity 184 member B, transcript variant X3
family with sequence similarity 184 member B, transcript variant X2
family with sequence similarity 184 member B, transcript variant X1
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mediator of RNA polymerase II transcription subunit 28
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
actin-related protein 2/3 complex subunit 3-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00554
integrin binding sialoprotein, transcript variant X1
integrin binding sialoprotein, transcript variant X2
integrin binding sialoprotein, transcript variant X3
matrix extracellular phosphoglycoprotein, transcript variant X2
matrix extracellular phosphoglycoprotein, transcript variant X1
matrix extracellular phosphoglycoprotein isoform X1
matrix extracellular phosphoglycoprotein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
polycystin 2, transient receptor potential cation channel
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X5
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X2
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X3
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X1
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X6
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X4
broad substrate specificity ATP-binding cassette transporter ABCG2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase, Mg2+/Mn2+ dependent 1K, transcript variant X1
protein phosphatase, Mg2+/Mn2+ dependent 1K, transcript variant X2
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC6 isoform X1
probable E3 ubiquitin-protein ligase HERC6 isoform X2
probable E3 ubiquitin-protein ligase HERC6 isoform X3
uncharacterized LOC122421996, transcript variant X2
uncharacterized LOC122421996, transcript variant X1
HECT and RLD domain containing E3 ubiquitin protein ligase 5
phosphatidylinositol glycan anchor biosynthesis class Y
phosphatidylinositol N-acetylglucosaminyltransferase subunit Y
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X1
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X3
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X2
probable E3 ubiquitin-protein ligase HERC3 isoform X1
probable E3 ubiquitin-protein ligase HERC3 isoform X2
family with sequence similarity 13 member A, transcript variant X13
family with sequence similarity 13 member A, transcript variant X3
family with sequence similarity 13 member A, transcript variant X2
family with sequence similarity 13 member A, transcript variant X4
family with sequence similarity 13 member A, transcript variant X1
family with sequence similarity 13 member A, transcript variant X12
family with sequence similarity 13 member A, transcript variant X7
family with sequence similarity 13 member A, transcript variant X11
family with sequence similarity 13 member A, transcript variant X6
family with sequence similarity 13 member A, transcript variant X5
family with sequence similarity 13 member A, transcript variant X9
family with sequence similarity 13 member A, transcript variant X10
family with sequence similarity 13 member A, transcript variant X8
tigger transposable element-derived protein 2
G protein-regulated inducer of neurite outgrowth 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
spectrin alpha chain, non-erythrocytic 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
coiled-coil serine rich protein 1, transcript variant X3
coiled-coil serine rich protein 1, transcript variant X1
coiled-coil serine rich protein 1, transcript variant X5
coiled-coil serine rich protein 1, transcript variant X2
coiled-coil serine rich protein 1, transcript variant X4
serine-rich coiled-coil domain-containing protein 1 isoform X1
serine-rich coiled-coil domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor delta type subunit 2, transcript variant X1
glutamate ionotropic receptor delta type subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, delta-2 isoform X2
glutamate receptor ionotropic, delta-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X2
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X1
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 isoform X2
hematopoietic prostaglandin D synthase, transcript variant X3
hematopoietic prostaglandin D synthase, transcript variant X1
hematopoietic prostaglandin D synthase, transcript variant X2
hematopoietic prostaglandin D synthase isoform X2
hematopoietic prostaglandin D synthase isoform X1
uncharacterized LOC122422307, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122422307, transcript variant X2
PDZ and LIM domain 5, transcript variant X1
PDZ and LIM domain 5, transcript variant X2
PDZ and LIM domain 5, transcript variant X8
PDZ and LIM domain 5, transcript variant X3
PDZ and LIM domain 5, transcript variant X4
PDZ and LIM domain 5, transcript variant X5
PDZ and LIM domain 5, transcript variant X6
PDZ and LIM domain 5, transcript variant X7
bone morphogenetic protein receptor type 1B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 26 ESTs, 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 26 ESTs, 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 26 ESTs, 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X5
bone morphogenetic protein receptor type 1B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 26 ESTs, 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X1
bone morphogenetic protein receptor type 1B, transcript variant X11
bone morphogenetic protein receptor type-1B isoform X1
bone morphogenetic protein receptor type 1B, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X8
bone morphogenetic protein receptor type 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 26 ESTs, 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor type-1B isoform X2
bone morphogenetic protein receptor type-1B isoform X3
bone morphogenetic protein receptor type-1B isoform X4
unc-5 netrin receptor C, transcript variant X2
unc-5 netrin receptor C, transcript variant X1
pyruvate dehydrogenase E1 subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 7 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase E1 subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial isoform X1
pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial isoform X2
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sperm-tail PG-rich repeat-containing protein 2
Rap1 GTPase-GDP dissociation stimulator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E, transcript variant X1
eukaryotic translation initiation factor 4E, transcript variant X3
eukaryotic translation initiation factor 4E, transcript variant X2
eukaryotic translation initiation factor 4E, transcript variant X4
eukaryotic translation initiation factor 4E isoform X1
eukaryotic translation initiation factor 4E isoform X3
eukaryotic translation initiation factor 4E isoform X2
eukaryotic translation initiation factor 4E isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins
alcohol dehydrogenase 5 (class III), chi polypeptide
alcohol dehydrogenase 4 (class II), pi polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
all-trans-retinol dehydrogenase [NAD(+)] ADH4
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: all-trans-retinol dehydrogenase [NAD(+)] ADH7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 ESTs, 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
tRNA methyltransferase 10A, transcript variant X2
tRNA methyltransferase 10A, transcript variant X4
tRNA methyltransferase 10A, transcript variant X3
tRNA methyltransferase 10A, transcript variant X1
tRNA methyltransferase 10 homolog A isoform X1
tRNA methyltransferase 10 homolog A isoform X2
microsomal triglyceride transfer protein
microsomal triglyceride transfer protein large subunit
chromosome 19 C4orf54 homolog, transcript variant X1
chromosome 19 C4orf54 homolog, transcript variant X2
dual adaptor of phosphotyrosine and 3-phosphoinositides 1, transcript variant X1
dual adaptor of phosphotyrosine and 3-phosphoinositides 1, transcript variant X2
dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide isoform X2
dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide isoform X1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X2
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X4
dnaJ homolog subfamily B member 14 isoform X1
dnaJ homolog subfamily B member 14 isoform X4
dnaJ homolog subfamily B member 14 isoform X2
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dnaJ homolog subfamily B member 14 isoform X3
DNA damage-inducible transcript 4-like protein
protein phosphatase 3 catalytic subunit alpha, transcript variant X2
protein phosphatase 3 catalytic subunit alpha, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
molybdopterin synthase sulfur carrier subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
B cell scaffold protein with ankyrin repeats 1, transcript variant X4
B cell scaffold protein with ankyrin repeats 1, transcript variant X1
B cell scaffold protein with ankyrin repeats 1, transcript variant X3
B cell scaffold protein with ankyrin repeats 1, transcript variant X2
B-cell scaffold protein with ankyrin repeats isoform X3
B-cell scaffold protein with ankyrin repeats isoform X1
B-cell scaffold protein with ankyrin repeats isoform X2
B-cell scaffold protein with ankyrin repeats isoform X4
solute carrier family 39 member 8, transcript variant X3
solute carrier family 39 member 8, transcript variant X1
solute carrier family 39 member 8, transcript variant X2
nuclear factor kappa B subunit 1, transcript variant X1
nuclear factor kappa B subunit 1, transcript variant X2
nuclear factor NF-kappa-B p105 subunit isoform X1
nuclear factor NF-kappa-B p105 subunit isoform X2
uncharacterized LOC122422052, transcript variant X1
uncharacterized LOC122422052, transcript variant X2
ubiquitin conjugating enzyme E2 D3, transcript variant X4
ubiquitin conjugating enzyme E2 D3, transcript variant X3
ubiquitin conjugating enzyme E2 D3, transcript variant X7
ubiquitin conjugating enzyme E2 D3, transcript variant X5
ubiquitin conjugating enzyme E2 D3, transcript variant X1
ubiquitin conjugating enzyme E2 D3, transcript variant X2
ubiquitin conjugating enzyme E2 D3, transcript variant X6
ubiquitin-conjugating enzyme E2 D3 isoform X2
ubiquitin-conjugating enzyme E2 D3 isoform X1
uncharacterized LOC122422030, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC122422030, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC122422030, transcript variant X1
CDGSH iron-sulfur domain-containing protein 2
solute carrier family 9 member B2, transcript variant X2
solute carrier family 9 member B2, transcript variant X1
sodium/hydrogen exchanger 9B2 isoform X2
sodium/hydrogen exchanger 9B2 isoform X1
solute carrier family 9 member B2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sodium/hydrogen exchanger 9B2 isoform X3
3-hydroxybutyrate dehydrogenase 2, transcript variant X3
3-hydroxybutyrate dehydrogenase 2, transcript variant X1
3-hydroxybutyrate dehydrogenase 2, transcript variant X2
3-hydroxybutyrate dehydrogenase type 2 isoform X1
3-hydroxybutyrate dehydrogenase type 2 isoform X2
centromere protein E, transcript variant X4
centromere protein E, transcript variant X2
centromere protein E, transcript variant X3
centromere protein E, transcript variant X1
centromere-associated protein E isoform X4
centromere-associated protein E isoform X2
centromere-associated protein E isoform X3
centromere-associated protein E isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 5 ESTs, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CXXC finger protein 4, transcript variant X7
CXXC-type zinc finger protein 4 isoform X2
CXXC finger protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CXXC finger protein 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X4
CXXC finger protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X6
CXXC-type zinc finger protein 4 isoform X1
uncharacterized LOC122422370, transcript variant X1
uncharacterized LOC122422370, transcript variant X2
tet methylcytosine dioxygenase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 16 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tet methylcytosine dioxygenase 2, transcript variant X5
tet methylcytosine dioxygenase 2, transcript variant X3
tet methylcytosine dioxygenase 2, transcript variant X1
tet methylcytosine dioxygenase 2, transcript variant X2
methylcytosine dioxygenase TET2 isoform X1
methylcytosine dioxygenase TET2 isoform X2
methylcytosine dioxygenase TET2 isoform X3
oral-facial-digital syndrome 1 protein-like
inorganic pyrophosphatase 2, transcript variant X2
inorganic pyrophosphatase 2, transcript variant X1
inorganic pyrophosphatase 2, mitochondrial isoform X2
inorganic pyrophosphatase 2, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Rho guanine nucleotide exchange factor 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutathione S-transferase C-terminal domain containing, transcript variant X1
glutathione S-transferase C-terminal domain containing, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutathione S-transferase C-terminal domain containing, transcript variant X3
glutathione S-transferase C-terminal domain containing, transcript variant X4
glutathione S-transferase C-terminal domain containing, transcript variant X2
glutathione S-transferase C-terminal domain-containing protein isoform X1
glutathione S-transferase C-terminal domain-containing protein isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
COORDINATES: nucleotide motif:Rfam:12.0:RF00108
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
TBC1 domain containing kinase, transcript variant X1
TBC1 domain containing kinase, transcript variant X2
TBC1 domain containing kinase, transcript variant X3
TBC domain-containing protein kinase-like protein
aminoacyl tRNA synthetase complex interacting multifunctional protein 1, transcript variant X1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1, transcript variant X2
aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X1
aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X2
GIMAP family P-loop NTPase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122422095, transcript variant X1
uncharacterized LOC122422095, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
dickkopf WNT signaling pathway inhibitor 2, transcript variant X2
dickkopf WNT signaling pathway inhibitor 2, transcript variant X1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1
sphingomyelin synthase 2, transcript variant X2
sphingomyelin synthase 2, transcript variant X3
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sphingomyelin synthase 2, transcript variant X1
sphingomyelin synthase 2, transcript variant X4
phosphatidylcholine:ceramide cholinephosphotransferase 2
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial
lymphoid enhancer binding factor 1, transcript variant X3
lymphoid enhancer binding factor 1, transcript variant X4
lymphoid enhancer binding factor 1, transcript variant X1
lymphoid enhancer binding factor 1, transcript variant X2
lymphoid enhancer binding factor 1, transcript variant X5
lymphoid enhancer binding factor 1, transcript variant X6
lymphoid enhancer-binding factor 1 isoform X3
lymphoid enhancer-binding factor 1 isoform X1
lymphoid enhancer-binding factor 1 isoform X5
lymphoid enhancer-binding factor 1 isoform X4
lymphoid enhancer-binding factor 1 isoform X2
lymphoid enhancer-binding factor 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
ribosomal protein L34, transcript variant X1
ribosomal protein L34, transcript variant X3
ribosomal protein L34, transcript variant X2
ribosomal protein L34, transcript variant X4
oligosaccharyltransferase complex non-catalytic subunit
oligosaccharyltransferase complex subunit OSTC
collagen type XXV alpha 1 chain, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X6
collagen type XXV alpha 1 chain, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
collagen type XXV alpha 1 chain, transcript variant X12
collagen type XXV alpha 1 chain, transcript variant X5
collagen type XXV alpha 1 chain, transcript variant X13
collagen type XXV alpha 1 chain, transcript variant X22
collagen type XXV alpha 1 chain, transcript variant X1
collagen type XXV alpha 1 chain, transcript variant X8
collagen type XXV alpha 1 chain, transcript variant X3
collagen type XXV alpha 1 chain, transcript variant X2
collagen type XXV alpha 1 chain, transcript variant X7
collagen type XXV alpha 1 chain, transcript variant X11
collagen type XXV alpha 1 chain, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X4
collagen type XXV alpha 1 chain, transcript variant X19
collagen type XXV alpha 1 chain, transcript variant X23
collagen type XXV alpha 1 chain, transcript variant X21
collagen type XXV alpha 1 chain, transcript variant X10
collagen type XXV alpha 1 chain, transcript variant X9
collagen type XXV alpha 1 chain, transcript variant X20
collagen type XXV alpha 1 chain, transcript variant X18
collagen type XXV alpha 1 chain, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
SEC24 homolog B, COPII coat complex component, transcript variant X1
SEC24 homolog B, COPII coat complex component, transcript variant X2
SEC24 homolog B, COPII coat complex component, transcript variant X5
SEC24 homolog B, COPII coat complex component, transcript variant X3
SEC24 homolog B, COPII coat complex component, transcript variant X4
protein transport protein Sec24B isoform X1
protein transport protein Sec24B isoform X2
protein transport protein Sec24B isoform X3
protein transport protein Sec24B isoform X4
protein transport protein Sec24B isoform X5
mitochondrial calcium uniporter dominant negative subunit beta
calcium uniporter regulatory subunit MCUb, mitochondrial
complement factor I, transcript variant X2
complement factor I, transcript variant X1
GAR1 ribonucleoprotein, transcript variant X2
GAR1 ribonucleoprotein, transcript variant X4
GAR1 ribonucleoprotein, transcript variant X1
H/ACA ribonucleoprotein complex subunit 1 isoform X1
GAR1 ribonucleoprotein, transcript variant X3
GAR1 ribonucleoprotein, transcript variant X5
H/ACA ribonucleoprotein complex subunit 1 isoform X2
retinal pigment epithelium-derived rhodopsin homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat, Ig-like and transmembrane domains 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine rich repeat, Ig-like and transmembrane domains 3, transcript variant X2
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 3 bases in 2 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pro-epidermal growth factor
ELOVL fatty acid elongase 6, transcript variant X2
ELOVL fatty acid elongase 6, transcript variant X1
elongation of very long chain fatty acids protein 6
paired like homeodomain 2, transcript variant X2
paired like homeodomain 2, transcript variant X3
paired like homeodomain 2, transcript variant X1
uncharacterized LOC122422300, transcript variant X2
uncharacterized LOC122422300, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 241 member A
adaptor related protein complex 1 associated regulatory protein, transcript variant X2
adaptor related protein complex 1 associated regulatory protein, transcript variant X1
AP-1 complex-associated regulatory protein isoform X1
AP-1 complex-associated regulatory protein isoform X2
adaptor related protein complex 1 associated regulatory protein, transcript variant X3
AP-1 complex-associated regulatory protein isoform X3
TRAF interacting protein with forkhead associated domain
TRAF-interacting protein with FHA domain-containing protein A
zinc finger GRF-type containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X2
zinc finger GRF-type containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X7
zinc finger GRF-type containing 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
La ribonucleoprotein 7, transcriptional regulator, transcript variant X4
La ribonucleoprotein 7, transcriptional regulator, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
La ribonucleoprotein 7, transcriptional regulator, transcript variant X3
La ribonucleoprotein 7, transcriptional regulator, transcript variant X5
La ribonucleoprotein 7, transcriptional regulator, transcript variant X1
La ribonucleoprotein 7, transcriptional regulator, transcript variant X6
La ribonucleoprotein 7, transcriptional regulator, transcript variant X2
calcium/calmodulin dependent protein kinase II delta, transcript variant X17
calcium/calmodulin dependent protein kinase II delta, transcript variant X10
calcium/calmodulin dependent protein kinase II delta, transcript variant X16
calcium/calmodulin dependent protein kinase II delta, transcript variant X4
calcium/calmodulin dependent protein kinase II delta, transcript variant X2
calcium/calmodulin dependent protein kinase II delta, transcript variant X18
calcium/calmodulin dependent protein kinase II delta, transcript variant X13
calcium/calmodulin dependent protein kinase II delta, transcript variant X8
calcium/calmodulin dependent protein kinase II delta, transcript variant X14
calcium/calmodulin dependent protein kinase II delta, transcript variant X9
calcium/calmodulin dependent protein kinase II delta, transcript variant X15
calcium/calmodulin dependent protein kinase II delta, transcript variant X3
calcium/calmodulin dependent protein kinase II delta, transcript variant X11
calcium/calmodulin dependent protein kinase II delta, transcript variant X6
calcium/calmodulin dependent protein kinase II delta, transcript variant X1
calcium/calmodulin dependent protein kinase II delta, transcript variant X5
calcium/calmodulin dependent protein kinase II delta, transcript variant X7
calcium/calmodulin dependent protein kinase II delta, transcript variant X12
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X13
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X14
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X17
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X10
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X9
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X16
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X18
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X15
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X11
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC122422127, transcript variant X2
uncharacterized LOC122422127, transcript variant X1
uncharacterized LOC122422127, transcript variant X3
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122422287, transcript variant X1
uncharacterized LOC122422287, transcript variant X2
uncharacterized LOC122422285, transcript variant X2
uncharacterized LOC122422285, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
2-hydroxyacylsphingosine 1-beta-galactosyltransferase
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4, transcript variant X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122422330, transcript variant X1
uncharacterized protein LOC122422330 isoform X1
uncharacterized LOC122422330, transcript variant X2
uncharacterized protein LOC122422330 isoform X2
uncharacterized LOC122422330, transcript variant X3
uncharacterized protein LOC122422330 isoform X3
translocation associated membrane protein 1 like 1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: translocating chain-associated membrane protein 1-like 1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X3
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00399
methyltransferase 14, N6-adenosine-methyltransferase subunit
N6-adenosine-methyltransferase non-catalytic subunit
SEC24 homolog D, COPII coat complex component, transcript variant X4
SEC24 homolog D, COPII coat complex component, transcript variant X1
SEC24 homolog D, COPII coat complex component, transcript variant X2
SEC24 homolog D, COPII coat complex component, transcript variant X3
protein transport protein Sec24D isoform X2
protein transport protein Sec24D isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
inactive ubiquitin carboxyl-terminal hydrolase 53
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphodiesterase 5A, transcript variant X2
phosphodiesterase 5A, transcript variant X1
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA phenylalanine (anticodon AAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
membrane associated ring-CH-type finger 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
E3 ubiquitin-protein ligase MARCHF1 isoform X1
membrane associated ring-CH-type finger 1, transcript variant X2
E3 ubiquitin-protein ligase MARCHF1 isoform X2
translation machinery associated 16 homolog
translation machinery-associated protein 16
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
neuropeptide Y receptor Y1, transcript variant X2
neuropeptide Y receptor Y1, transcript variant X1
neuropeptide Y receptor Y1, transcript variant X3
nuclear assembly factor 1 ribonucleoprotein
H/ACA ribonucleoprotein complex non-core subunit NAF1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pyroglutamylated RFamide peptide receptor
pyroglutamylated RF-amide peptide receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
neuron derived neurotrophic factor, transcript variant X2
neuron derived neurotrophic factor, transcript variant X1
PR domain zinc finger protein 5 isoform X1
PR domain zinc finger protein 5 isoform X2
PR domain zinc finger protein 5 isoform X3
PR domain zinc finger protein 5 isoform X4
uncharacterized LOC122422202, transcript variant X2
uncharacterized LOC122422202, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitotic spindle assembly checkpoint protein MAD2A
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X2
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X2
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X4
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X6
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X5
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X3
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X5
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X4
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X1
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X6
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments